NUWE:NASDAQ, Nuwellis, Inc.
NUWE stock overview
Nuwellis, Inc. (NUWE:NASDAQ) closed at $5.68 on October 30, 2026,
down 1.73% on the day.
The stock trades 99.6% below its 52-week high of $1,556.10
and 125.4% above its 52-week low of $2.52.
Over the past year, it gained 98.6%.
Nuwellis, Inc. is part of the Health Care sector.
Key figures
- Price
- $5.68
- Day change
- -1.73%
- Volume
- 302,303
- Average volume
- 897,871
- Market cap
- 2M+
- 52-week range
- $2.52 – $1,556.10
- 50-day average
- $6.73
- 200-day average
- $241.55
Price action over the past year
In 250 trading sessions since October 30, 2025, NUWE closed higher on 82 days (33%).
Its best day was July 30, 2026 (+135.45%) and its worst was July 31, 2026 (-60.90%).
The stock moved 10% or more in a single session 36 times.
It opened at least 5% above the previous day's high 4 times.
Recent signals
NUWE news
-
Oct 27, 2026:
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
-
Oct 8, 2026:
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
-
Oct 8, 2026:
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian Pediatric CRRT System
-
Oct 1, 2026:
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
-
Sep 17, 2026:
Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
-
Sep 17, 2026:
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
-
Sep 16, 2026:
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
-
Sep 9, 2026:
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
About Nuwellis, Inc.
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.
Similar stocks
Find more stocks like NUWE with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.